JP2025024031A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2025024031A5 JP2025024031A5 JP2024195152A JP2024195152A JP2025024031A5 JP 2025024031 A5 JP2025024031 A5 JP 2025024031A5 JP 2024195152 A JP2024195152 A JP 2024195152A JP 2024195152 A JP2024195152 A JP 2024195152A JP 2025024031 A5 JP2025024031 A5 JP 2025024031A5
- Authority
- JP
- Japan
- Prior art keywords
- domain
- cell
- seq
- intracellular
- cd1a
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19382104.8 | 2019-02-14 | ||
| EP19382104.8A EP3696191A1 (en) | 2019-02-14 | 2019-02-14 | Car t-cells for the treatment of cd1a-positive cancer |
| PCT/EP2020/053769 WO2020165350A1 (en) | 2019-02-14 | 2020-02-13 | Car t-cells for the treatment of cd1a-positive cancer |
| JP2021547571A JP7590737B2 (ja) | 2019-02-14 | 2020-02-13 | ＣＤ１ａ陽性癌の治療のためのＣＡＲ Ｔ細胞 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021547571A Division JP7590737B2 (ja) | 2019-02-14 | 2020-02-13 | ＣＤ１ａ陽性癌の治療のためのＣＡＲ Ｔ細胞 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025024031A JP2025024031A (ja) | 2025-02-19 |
| JP2025024031A5 true JP2025024031A5 (https=) | 2025-07-08 |
Family
ID=65685281
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021547571A Active JP7590737B2 (ja) | 2019-02-14 | 2020-02-13 | ＣＤ１ａ陽性癌の治療のためのＣＡＲ Ｔ細胞 |
| JP2024195152A Pending JP2025024031A (ja) | 2019-02-14 | 2024-11-07 | ＣＤ１ａ陽性癌の治療のためのＣＡＲ Ｔ細胞 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021547571A Active JP7590737B2 (ja) | 2019-02-14 | 2020-02-13 | ＣＤ１ａ陽性癌の治療のためのＣＡＲ Ｔ細胞 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US12215158B2 (https=) |
| EP (2) | EP3696191A1 (https=) |
| JP (2) | JP7590737B2 (https=) |
| CN (2) | CN118436770A (https=) |
| AU (1) | AU2020222239B2 (https=) |
| CA (1) | CA3128955A1 (https=) |
| MX (1) | MX2021009798A (https=) |
| WO (1) | WO2020165350A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3696191A1 (en) * | 2019-02-14 | 2020-08-19 | Fundación Instituto de Investigación contra la Leucemia Josep Carreras (IJC) | Car t-cells for the treatment of cd1a-positive cancer |
| US11746154B2 (en) | 2020-10-09 | 2023-09-05 | Pfizer Inc. | CD1a antibodies and uses thereof |
| AU2022282828A1 (en) * | 2021-05-26 | 2023-12-14 | Oxford University Innovation Limited | Antibodies |
| IT202100027929A1 (it) * | 2021-11-02 | 2023-05-02 | Univ Degli Studi Magna Graecia Di Catanzaro | Un nuovo anticorpo bispecifico asimmetrico(UMG2/CD1a-CD3e) per il trattamento immunologico della forma corticale di leucemia linfoblastica acuta T (T-ALL) pediatrica e dell’adulto |
| EP4234582A1 (en) * | 2022-02-28 | 2023-08-30 | Onechain Immunotherapeutics SL | Humanized cd1a targeting moiety for the treatment of cd1a-positive cancer |
| CA3251493A1 (en) * | 2022-02-28 | 2023-08-31 | Onechain Immunotherapeutics S.L | Humanized CD1A Targeting Fraction for Treating CD1A-Positive Cancer |
| GB202217923D0 (en) * | 2022-11-29 | 2023-01-11 | Univ Oxford Innovation Ltd | Antibodies |
| EP4417623A1 (en) * | 2023-02-15 | 2024-08-21 | Fundació Institut de Recerca Contra la Leucèmia Josep Carreras | Ccr9 targeting moiety for the treatment of ccr9-positive cancer |
| EP4545085A1 (en) * | 2023-10-26 | 2025-04-30 | Fundación Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz | Car t-cells against cd79b for the treatment of non-hodgkin lymphoma |
| CN119685260B (zh) * | 2024-12-17 | 2026-01-13 | 上海交通大学医学院附属瑞金医院 | 一种具有新型穿膜区的嵌合抗原受体t细胞及其应用 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0436597B1 (en) | 1988-09-02 | 1997-04-02 | Protein Engineering Corporation | Generation and selection of recombinant varied binding proteins |
| US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
| US5427908A (en) | 1990-05-01 | 1995-06-27 | Affymax Technologies N.V. | Recombinant library screening methods |
| EP0585287B1 (en) | 1990-07-10 | 1999-10-13 | Cambridge Antibody Technology Limited | Methods for producing members of specific binding pairs |
| GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
| CA2405246A1 (en) | 1990-12-03 | 1992-06-11 | Genentech, Inc. | Enrichment method for variant proteins with alterred binding properties |
| EP0575485A1 (en) | 1991-03-01 | 1993-12-29 | Dyax Corp. | Process for the development of binding mini-proteins |
| DK0580737T3 (da) | 1991-04-10 | 2004-11-01 | Scripps Research Inst | Heterodimere receptorbiblioteker ved anvendelse af phagemider |
| DE4122599C2 (de) | 1991-07-08 | 1993-11-11 | Deutsches Krebsforsch | Phagemid zum Screenen von Antikörpern |
| GB0717101D0 (en) * | 2007-09-03 | 2007-10-10 | Cambridge Entpr Ltd | Tumour marker |
| AU2015327868A1 (en) | 2014-10-03 | 2017-04-20 | Novartis Ag | Combination therapies |
| CN107708741A (zh) * | 2015-06-12 | 2018-02-16 | 免疫医疗公司 | 用嵌合抗原受体(car)构建体和表达car构建体的t细胞(car‑t)或nk细胞(car‑nk)进行的疾病疗法 |
| EP3696191A1 (en) * | 2019-02-14 | 2020-08-19 | Fundación Instituto de Investigación contra la Leucemia Josep Carreras (IJC) | Car t-cells for the treatment of cd1a-positive cancer |
-
2019
- 2019-02-14 EP EP19382104.8A patent/EP3696191A1/en not_active Withdrawn
-
2020
- 2020-02-13 EP EP20706418.9A patent/EP3924374A1/en active Pending
- 2020-02-13 MX MX2021009798A patent/MX2021009798A/es unknown
- 2020-02-13 US US17/430,705 patent/US12215158B2/en active Active
- 2020-02-13 WO PCT/EP2020/053769 patent/WO2020165350A1/en not_active Ceased
- 2020-02-13 CA CA3128955A patent/CA3128955A1/en active Pending
- 2020-02-13 JP JP2021547571A patent/JP7590737B2/ja active Active
- 2020-02-13 AU AU2020222239A patent/AU2020222239B2/en active Active
- 2020-02-13 CN CN202410679216.9A patent/CN118436770A/zh active Pending
- 2020-02-13 CN CN202080028333.9A patent/CN113795506A/zh active Pending
-
2024
- 2024-11-07 JP JP2024195152A patent/JP2025024031A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025024031A5 (https=) | ||
| CN110662771A (zh) | 一种结合bcma的嵌合抗原受体(car)及其应用 | |
| JP2025028239A5 (https=) | ||
| TWI817302B (zh) | 改良的雙特異性多肽分子 | |
| JP2022501043A5 (https=) | ||
| FI3749338T3 (fi) | Humanisoitu bcma vasta-aine ja bcma-car-t solut | |
| JP2020533958A5 (https=) | ||
| KR20050108349A (ko) | 영속적인 티 세포 반응을 유도하는 삼량체 폴리펩티드 구조물 | |
| EP3337507A1 (en) | Bispecific monovalent diabodies that are capable of binding b7-h3 and cd3, and uses thereof | |
| JP2021500881A5 (https=) | ||
| JP2020511529A5 (https=) | ||
| CA3102331A1 (en) | Novel anti-sirpa antibodies | |
| JPWO2020061498A5 (https=) | ||
| IL273393B1 (en) | New anti-CD3 epsilon antibodies | |
| CN111484555A (zh) | 新型双特异性cd3/cd20多肽复合物 | |
| IL274806B1 (en) | T-cells comprising anti-cd38 and anti-cd138 chimeric antigen receptors and uses thereof | |
| JPWO2020228824A5 (https=) | ||
| EP4490194A1 (en) | Novel anti-cd3 antibodies and uses thereof | |
| JPWO2020228825A5 (https=) | ||
| CN116917316A (zh) | 与NKp30结合的抗体分子及其用途 | |
| JPWO2020165350A5 (https=) | ||
| WO2024131962A1 (zh) | 新型抗gprc5d抗体 | |
| JPWO2019245991A5 (https=) | ||
| TW202309294A (zh) | 病毒載體生產系統 | |
| JPWO2021016585A5 (https=) |